Clinical Trial

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

Name: Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma — clinical trial record (NCT07274787)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and early effectiveness of the NaviFUS system with concomitant microbubble administration in conjunction with BEV in recurrent GBM patients.

Trial Details

NCT Number	NCT07274787
Lead Sponsor	University of Cincinnati Collaborators: NaviFUS Corporation
Conditions	GBM
Enrollment	10 participants
Start Date	2026-12-01
Primary Completion	2028-12-01 (estimated)
Study Completion	2029-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-04